Brief: KORU Medical Systems Signs Supply Agreement For A Phase III Clinical Trial
14/05/2024 21:27
May 14 (Reuters) - KORU Medical Systems Inc KRMD.O :
* KORU MEDICAL SYSTEMS SIGNS SUPPLY AGREEMENT FOR A PHASE
III
CLINICAL TRIAL FOR A NOVEL ENDOCRINOLOGICAL BIOLOGIC
Source text for Eikon: ID:nBw6d7gkza
Further company coverage: KRMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Koru Medical Systems
See all newsKoru Medical Systems Inc Reports Results For The Quarter Ended June 30: Earnings Summary
KORU Medical Q2 returns to profit on lower manufacturing costs and higher average selling prices
Brief: KORU Medical Systems Q2 Operating Expenses USD 7.2 Million
Koru Medical Systems Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview
Brief: Koru Medical Systems - Enters Amendment No. 1 To Supply Agreement With Command Medical Products On June 24, 2026 - SEC Filing